165 related articles for article (PubMed ID: 14960057)
1. Transcatheter PFO closure in an aircrew member with cryptogenic stroke: aeromedical disposition.
Johnson EG; McCrary BF; Kruyer WB
Aviat Space Environ Med; 2004 Feb; 75(2):180-3. PubMed ID: 14960057
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
[TBL] [Abstract][Full Text] [Related]
3. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous transcatheter closure of patent foramen ovale.
Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA
Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter coil occlusion of residual shunt in a patient with recurrent cryptogenic stroke after PFO percutaneous closure.
Donti A; Giardini A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Picchio FM
Catheter Cardiovasc Interv; 2004 Mar; 61(3):415-7. PubMed ID: 14988907
[TBL] [Abstract][Full Text] [Related]
6. Patent foramen ovale in cryptogenic stroke: current understanding and management options.
Wu LA; Malouf JF; Dearani JA; Hagler DJ; Reeder GS; Petty GW; Khandheria BK
Arch Intern Med; 2004 May; 164(9):950-6. PubMed ID: 15136302
[TBL] [Abstract][Full Text] [Related]
7. Migraine headache relief after transcatheter closure of patent foramen ovale.
Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA
J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692
[TBL] [Abstract][Full Text] [Related]
8. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia.
Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614
[TBL] [Abstract][Full Text] [Related]
9. Patent foramen ovale and cerebrovascular diseases.
Desai AJ; Fuller CJ; Jesurum JT; Reisman M
Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):446-55. PubMed ID: 16874357
[TBL] [Abstract][Full Text] [Related]
10. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
11. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
13. [Thrombophilia and patent foramen ovale in young stroke patients].
Carod-Artal FJ; Vilela Nunes S; Portugal D
Neurologia; 2006 Dec; 21(10):710-6. PubMed ID: 17106824
[TBL] [Abstract][Full Text] [Related]
14. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation following device closure of patent foramen ovale.
Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter closure of patent foramen ovale in patients with migraine headache.
Spies C; Schräder R
J Interv Cardiol; 2006 Dec; 19(6):552-7. PubMed ID: 17107372
[TBL] [Abstract][Full Text] [Related]
18. A novel technique to prevent displacement of inferior vena cava filter during cardiac catheterization with subsequent transcatheter closure of a patent foramen ovale in a patient with cryptogenic shock.
Recto MR; Sobczyk WL
J Invasive Cardiol; 2002 Aug; 14(8):471-3. PubMed ID: 12147881
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N
Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale.
Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
Int J Cardiol; 2007 Sep; 120(3):357-62. PubMed ID: 17166607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
